Back to Journals » Therapeutics and Clinical Risk Management » Volume 12

New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib

Total article views   HTML views PDF downloads Totals
20,667 Dovepress* 17,649+ 1,886 19,535
PubMed Central* 3,018 362 3,380
Totals 20,667 2,248 22,915
*Since 5 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
16 0 0 1 7 8

View citations on PubMed Central and Google Scholar